期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

宫颈癌hMSH2及PCNA的异常表达 被引量：1

Abnormal expression of hMSH2 and PCNA in cervical carcinoma
下载PDF
导出
摘要 [目的]探讨错配修复蛋白(hMSH2)及增殖细胞核抗原PCNA异常表达在宫颈癌发病中的意义。[方法]免疫组织化学SP法检测67例宫颈癌和22例非癌子宫颈上皮组织hMSH2与PCNA的表达情况。[结果]宫颈癌组hMSH2阳性表达率为55.20%(37/67),高于非癌上皮组的27.30%(6/22)(P<0.05);宫颈癌组PCNA阳性表达率为73.10%(49/67),高于非癌上皮组的59.10%(13/22),但差异不显著(P>0.05)。宫颈癌hMSH2表达阳性组的PCNA阳性表达率为83.30%(31/37),高于hMSH2表达阴性组的60.00%(12/30)(P<0.05)。[结论]错配修复蛋白(hMSH2)与增殖细胞核抗原PCNA相互影响共同参与宫颈癌的发生。 [Objective] To study the significance of abnormal expressions of DNA mismatch repair protein （hMSH2） and proliferating cell nuclear antigen （PCNA） in cervical carcinogenesis. [Methods] Immunohistochemistry SP method was used to detect the expressions of hMSH2 and PCNA in 67 cervical carcinomas and 22 cervical non - carcinoma eptheis. [Results] The positive expression rate of hMSH2 in cervical carcinoma group being 55.20% was higher than that in cervical non - carcinoma epithchiam group being 27.3% （P 〈 0.05）; the positive expression rates of PCNA in cervical carcinoma group and cervical non - carcinoma epithcham group were 73.10% and 59.10% （P 〉 0.05）; the positive expression rate of PCNA of cervical carcinoma with the hMSH2 expression being 83.30% was higher than that without the h MSH2 expression being 60.00% （P 〈 0.05）. [Conclusion] Interaction between mismatch repair protein （hMSH2） and proliferating cell nuclear antigen PCNA may contribute to carcinogenesis of cervical carcinoma.
作者 王彦 王丽宏 赵赫男 王朝晖 李梅 吕申
机构地区 大连医科大学第二临床学院中心实验室 大连医科大学病理生理教研室
出处 《大连医科大学学报》 CAS 2006年第5期373-375,共3页 Journal of Dalian Medical University
关键词 宫颈癌 HMSH2 PCNA 免疫组织化学 cervical carcinoma hMSH2 PCNA immunohistochemistry
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献4

  • 1Peltomaki P.DNA mismatch repair andcancer[J].Mutat Res,2001,488(1):77-85.
  • 2周琪,阎晓初.人类错配修复基因突变在大肠肿瘤发生中的作用研究新进展[J].重庆医学,2004,33(7):1044-1047. 被引量：4
  • 3Dierendonck JH,Wijsman JH,Keijzer R,et a1.Gell-gele-related staining patterns ofantiprolierating cell nuclear antigen monoclonal antiboies.Comparison with Brd Urd1abeling and ki-67 staining[J].Am J Pathol.1991,138(5):1165.
  • 4Garciq RL,Lortrera MD,Gown AM.Analysis of proliferative glade usinganti-PCNA/cyclinmonoclonal antibodies infixed embedded tissue;comparision with flowcytometreic analysis[J].Am J Pathol,1989,134:733-739.

二级参考文献21

  • 1Riccardo D,Alessandra V,Claudio D,et al.High prevalence of activatied intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinoma with microsatellite instability[J].Am J Pathol,1999,154:1805
  • 2Shigemasa K,Yokozaki H,Honda N,et al.Microsatellite instability and hMSH2 gene mutation in a triple cancer (colon cancer,endometrial cancer,ovarian cancer) patient in hereditary non-polyposis colorectal cancer (HNPCC) kindred[J].J Obstet Gynaecol Res,1999
  • 3Zhang H,Richards B,Wilson T,et al.Apoptosis induced by overexpression of hMSH2 or hMLH1[J].Cancer Res,1999,59(13): 3021
  • 4Jiricny,Nystrom-Lahti M.Mismatch repair defects in cancer[J].Curr Opin Genet,2000,10:157
  • 5Kohonen MR,Daniel JJ,Riele H,et al.Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors[J].Cancer Res,2002,62(7):2092
  • 6Noffsinger AE,Belli JM,Fogt F,et al.A germline hMSH2 alteration is unrelated to colonic microsatellite instability in patients with ulcerative colitis[J].Hum Pathol,1999,30:8
  • 7Cawkwell L,Sutherland F,Murgatoryd H,et al.Defective hMSH2/hMLH1 protein expression in seen infrequently in ulcerative colitis associated colorectal cancers[J].Gut,2000,46:367
  • 8Toyota M,Lssa JP.CpG island methylator phenotypes in aging and cancer[J].Semin Cancer Biol,1999,9:349
  • 9Kuismanen SA,Holmberg MT,Salovaara R,et al.Epigenetic in phenotypes distinguish microsatellite stable and unstable colorectal cancer[J].Proc Natl Acad Ssi USA,1999,96:12661
  • 10Bariol C,Suter C,Cheong K,et al.The relationship between hypomethylation and CpG island methylation in colorectal neoplasia[J].Am J Pathol,2003,162(4):1361

共引文献3

同被引文献6

  • 1Gakiopoulou H, Korkolopoulou P, Levidou G, et al. Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours : relationship with cell cycle regulators and prognostic implications [J]. Br J Cancer, 2007,97(8) : 1124-1134.
  • 2Williams G H, Romanowski P, Morris L, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication [J]. Proc Natl Acad Sci USA, 1998,95(25) : 14932-14937.
  • 3Freeman A, Morris L S, Mills A D, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy [J]. Clin Cancer Res, 1999,5(8) :2121-2132.
  • 4Vandeputte G, Kristensen G B, Lie A K, et al. CyclinS and proliferation markers in early squamous cervical carcinoma [J]. Gynecol Oncol, 2004,8 ( 1 ) : 40-46.
  • 5Pawlikowski M, Gruszka A, Kurnatowska I, et al. Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma [J]. Folia Histochem Cytobiol, 2006,44( 1 ) : 37-41.
  • 6Laitakari J, Harrison D, Stenbck F. Automated image analysis of proliferating cells in carcinoma of the larynx [J]. Acta Otolaryngol, 2003,123 (6) :759-766.

引证文献1

大连医科大学学报
2006年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部